The Virtual Cell Pharmacology Initiative (VCPI) is an open source platform designed to build a standardized framework for virtual cell models.

Novartis’ $23 billion investment in U.S.-based infrastructure over the next five years is designed to increase manufacturing capacity.

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

The study evaluates the long-term cognitive abilities in the mice with over expression of Sox9 or elimination of the gene.

In a study in IBD patients, scientists observed shifts in gut chemistry, among other changes, that could lead to new treatment strategies.

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

MagGel-BS platform addresses challenges related to the targeted delivery and subsequent recovery of engineered bacteria within the GI tract.

PERT edits the genome to permanently express a suppressor tRNA, so that cells affected by nonsense mutations can produce functional protein.

Model recapitulates key physiological features of native endosteal niches, and could aid in the study of blood formation in both healthy and diseased conditions.

Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

Starting in 2026, NIBRT training will be piloted at Heartland BioWorks’ Indianapolis headquarters with hands-on training beginning in 2027.